An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01970111 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2016-04-18
Summary
The purpose of this study is to evaluate the long-term safety, efficacy, and pharmacokinetics of KPS-0373 in SCD patients.
Conditions
- Spinocerebellar Degeneration
Interventions
- DRUG
-
KPS-0373, High dose
- DRUG
-
KPS-0373, Low dose
Sponsors & Collaborators
-
Kissei Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2015-07-31
Countries
- Japan
More Related Trials
-
A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3
NCT05160558 ·Status: TERMINATED ·Phase: PHASE1
-
Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)
NCT00931944 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
NCT01096095 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3
NCT02227823 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients
NCT03917225 ·Status: COMPLETED ·Phase: PHASE2
-
Dalfampridine and Gait in Spinocerebellar Ataxias
NCT01811706 ·Status: COMPLETED ·Phase: NA
-
Troriluzole in Adult Participants With Spinocerebellar Ataxia
NCT03701399 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy
NCT00374075 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Efficacy, and Tolerability of NBI-827104 for the Treatment of Essential Tremor
NCT04880616 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia
NCT06874010 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants
NCT06772870 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Lithium Treatment for Patients With Spinocerebellar Ataxia Type I
NCT00683943 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
NCT01114737 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA
NCT05544058 ·Status: COMPLETED
-
Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia
NCT00824512 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia
NCT05285540 ·Status: COMPLETED ·Phase: PHASE1
-
Lithium in Multiple System Atrophy
NCT00997672 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome
NCT00051961 ·Status: COMPLETED
-
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
NCT00557973 ·Status: COMPLETED ·Phase: PHASE2
-
STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
NCT05490563 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Phase 2 RCT Study of CX-8998 for Essential Tremor
NCT03101241 ·Status: COMPLETED ·Phase: PHASE2
-
Valproate and Levocarnitine in Children With Spinal Muscular Atrophy
NCT01671384 ·Status: UNKNOWN ·Phase: PHASE3
-
Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia
NCT00111371 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy
NCT04539041 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
NCT01096082 ·Status: COMPLETED ·Phase: PHASE2/PHASE3